Posts Tagged: west cancer clinic
West Physicians Publish a Study on the Establishment of a Molecular Tumor Board & Uptake of Recommendations in a Community Setting
West physicians Dr. Ari VanderWalde, Dr. Axel Grothey, Dr. Daniel Vaena, Dr. Gregorgy Vidal, Dr. Adam ElNaggar, & Dr. Lee Schwartzberg recently published a study on the establishment of a Molecular Tumor Board & Uptake of Recommendations in a Community Setting. Abstract In the precision medicine era, molecular testing in advanced cancer is foundational… Read more »
Dr. Gregory Vidal Discusses Use of Patient Registries in Neratinib Study
Gregory Vidal, MD, PhD, West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in HER2-positive breast cancer. Gregory Vidal, MD, PhD, of West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in… Read more »
OneR and West Cancer Physicians Give Ten Presentations at SABCS
OneR and West Cancer Physicians Give Ten Presentations at SABCS OneOncology, the national network of independent oncology practices, announced today that physicians from OneR, the OneOncology Research Network and West Cancer and Research Institute will share results from ten research studies at the San Antonio Breast Cancer Symposium® (SABCS®), an international gathering of physicians and… Read more »
Grothey Published in NEJM for Colorectal Cancer Care
Axel Grothey, MD The New England Journal of Medicine (NEJM) has recently published an editorial entitled “Pembrolizumab as first-line therapy in mismatch repair-deficient advanced colorectal cancer: A new standard of care” written by West Cancer Center’s GI Medical Oncology Lead and GI Oncology Clinical Research Director, Dr. Axel Grothey. Click the link below… Read more »
West Cancer Center & Research Institute, through affiliate OneR & Genentech, Launches New Clinical Trial Targeting Actionable Mutation Study in Cancer
Matching patient populations with a targetable genomic alteration to a specific investigational study is the aim of a new clinical trial through OneR and Genentech. This partnership will facilitate collaborations on various clinical trials, scientific research and real-world data studies that will advance personalized cancer care at community oncology centers like West. “With too many… Read more »